| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0001 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -7.9e-06 | 1 |